Chief Scientific Advisor
Dr. Satyam S. Nampalli received his Ph.D., in Organic Chemistry at National Chemical Laboratory, Pune, India. He pursued his Postdoctoral Research at Madison, WI and Athens, GA, USA on the synthesis of Natural Products, anti-HIV and anti-Cancer drugs.
Dr. Nampalli has over 30 years of experience in the field of Biotech and Pharmaceutical Industry. He is a founding partner and COO of American BioInnovations LLC, Sparks, MD, USA and has been operating since 2012. Dr. Nampalli serves as a Scientific Advisory Board Member @ both Erythro & SynInnova Organizations further making a successful Erythro-ABI-SynInnova Triad Partnership in Small Molecule Drug Intermediates, APIs, & Custom Synthesis. Prior to establishing American BioInnovations, he worked in various reputed organizations as briefly mentioned below:
Senior Manager: At Life Technologies on AGT Cell Culture Media Supplements and Reagents.
Program Manager: At BD in the field of Cell Culture & Stem Cell Culture Area for Bio-Pharmaceuticals Production.
Consultant: At Lonza on Cell Culture Media & Troubleshooting.
Program Manager: At J & J Biophamaceuticals
Director of Chemistry: At Apicore for Small Molecule Drugs’ Development & APIs productions.
Senior Scientist and Manager: At Amersham Biosciences on various Nucleosides, Nucleotides & DNA Sequencing Chemistry Technology, which enabled the Whole Human Genome Sequencing Efforts.